Enter your login e-mail to the account
Search
Search parameters
Search results
- INTOXIKÁCIA CHLÓROM (Cl–) A ČPAVKOM (NH3)
MUDr. Viliam Dobiáš, PhD.
(2/2008, Memorix ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles ) - CHRONIC LYMPHOCYTIC LEUKEMIA
prof. MUDr. Elena Tóthová, CSc.
(12/2008, Topic )
- Immunological outlook on modern therapy of multiple sclerosis
doc. MUDr. Vojtěch Thon, Ph.D.
(5/2016, From the boundary of neurology ) - Surprising laboratory findings in CSF
doc. MUDr. Pavel Adam, CSc., MUDr. Ondřej Sobek, CSc., MUDr. Martina Koudelková
(5/2012, Case reports ) - Alemtuzumab in the treatment of multiple sclerosis: a haematologist perspective
Prof. MUDr. Tomáš Kozák, Ph.D.
(6/2016, From the boundary of neurology ) - Monoklonální protilátky v léčbě roztroušené sklerózy
MUDr. Marek Peterka , MUDr. Zdeněk Kasl, Ph.D.
(2/2018, Pharmacotherapy ) - B lymfocyty v roztroušené skleróze mozkomíšní a postavení biologika cílícího na B lymfocyty v její léčbě
prof. RNDr. Jan Krejsek, CSc.
(3/2018, From the boundary of neurology ) - Neurologické komplikace hemoblastóz
MUDr. David Doležil, Ph.D.
(1/2005, Main topic )
- Differential diagnosis of lymphadenopathy and lymphocytosis, indolent lymphomas
MUDr. Miloš Nosáľ, PhD.
(6/2014, Oncohematology Review ) - PHARMACOECONOMICAL EVALUATION OF ONCOLOGY DRUGS – DIFFICULTIES AND POSSIBLE SOLUTIONS
doc. MUDr. Ján Bielik, CSc., PharmDr. Dominikk Tomek, MPH
(1/2008, Review articles ) - Monoclonal antibodies in the treatment of chronic lymphocytic leukemia
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová, MUDr. Juraj Chudej, PhD.
(6/2014, Oncohematology Review ) - PHARMACOECONOMIC EVALUATION OF DOCETAXEL IN INDUCTION CHEMOTHERAPY OF LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
PharmDr. Dominik Tomek, MPH, MUDr. Milan jamárik
(1/2008, Review articles ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - Blastic transformation of indolent lymphomas
MUDr. Jan Hudeček, CSc.
(1/2007, Review articles ) - Milí čitatelia! - úvodné slovo
prof. MUDr. Stanislav Špánik, CSc.
(1/2011, Editorial ) - The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - Lymphoma biologic therapy
MUDr. Andrej Vranovský, PhD.
(1/2011, Review articles ) - Current possibilities of treatment of chronic B-lymphocytic leukemia in Slovakia and world
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2022, Review articles ) - MALIGNANT LYMPHOMA DIAGNOSIS FROM THE PATHOLOGIST´S POINT OF VIEW
prof. MUDr. Lukáš Plank, CSc.
(2/2008, Review articles ) - The genetic profile is determinating the choice of treatment of de-novo patients with chronic lymphocytic leukemia
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD., MUDr. Jozef Lukáš, PhD.
(2/2024, Review articles ) - Chronic lymphocytic leukemia - how to treat a patient with relapsed or refractory disease in the era of signaling pathway inhibitors
MUDr. Firas Farkaš, PhD.
(1/2022, Case reports ) - Innovative treatment of chronic lymphocytic leukemia using chemo-free strategies, ringing the bell for chemotherapy?
MUDr. Firas Farkaš, PhD.
(5/2021, Review articles ) - SPRÁVA ZO 49. MÍTINGU AMERICKEJ HEMATOLOGICKEJ SPOLOČNOSTI (ASH) V ATLANTE
MUDr. Andrej Vranovský
(2/2008, Events ) - The polymorphisms of DNA-repair genes in pathogenesis of NHL
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD., RNDr. Lucia Klimčáková, PhD., prof. RNDr. Ján Šalagovič, CSc.
(6/2013, Review articles ) - Follow-up after treatment in patients with malignant disease
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Andrej Rosík, MUDr. Miroslava Stratená, MUDr. Mário Bôžik
(3/2015, Main topic ) - Cytogenetic and molecular cytogenetic methods in hemato-oncology
Mgr. Petra Nováková, MUDr. Denisa Ilenčíková, PhD.
(2/2010, Review articles ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - Patient registries – a need for real data in the context of efficacy, safety and cost effectiveness
PharmDr. Dominik Tomek, MPH, RNDr. Mária Pšenková, Ing. Branislav Balvan
(2/2010, Review articles ) - New trends in the immunotherapy of cancer
MUDr. Ján Lakota, CSc.
(6/2016, Review articles ) - Criteria of the oncology drugs categorisation process on use of the principle „the value for money“ from the point of view of expected benefits
MVDr., Mgr. Peter Mrva, MPH
(2/2017, Main topic ) - Lymfómové fórum 2010
MUDr. Miriam Ladická
(2/2010, Events ) - Horizontal scanning and fast scanning system of anticancer treatment in Slovakia. The first results of the pilot project
PharmDr. Dominik Tomek, PhD., MPH1, prof. MUDr. Jozef Holomáň, CSc., MVDr. Peter Mrva, MPH
(2/2017, Main topic ) - Classification and diagnostics of indolent B-cell neoplasms in the context of the new WHO classification 2016
MUDr. Tomáš Balhárek, PhD., prof. MUDr. Lukáš Plank, CSc.
(2/2017, Spectrum ) - Články publikované v časopise Onkológia v roku 2012 (7. ročník)
(1/2013, online attachment ) - Lymphoma in pregnancy
MUDr. Veronika Ballová
(3/2016, Main topic ) - 11. medzinárodná konferencia o malígnych lymfómoch v Lugane
MUDr. Veronika Ballová
(4/2011, Events ) - The use of immunotherapy in pediatric oncology
MUDr. Viera Bajčiová, CSc.
(1/2014, Review articles ) - WALDENSTRÖM‘S MACROGLOBULINEMIA – EPIDEMIOLOGY, ETHIOPATOGENESIS, DIAGNOSTIC AND TREATMENT
prof. MUDr. Elena Tóthová, CSc.
(5/2008, Review articles ) - Správa z 15. kongresu Európskej hematologickej spoločnosti v Barcelone
MUDr. Ľudmila Demitrovičová
(5/2010, Events ) - Multipotent cell-mediated drug resistance
doc. MUDr. Štefan Polák, CSc., Mgr. Lucia Kučerová, PhD., RNDr. Lenka Baranovičová, Mgr. Svetlana Školeková, MUDr. Martin Boháč
(4/2013, Review articles ) - CHRONIC LYMPHOCYTIC LEUKEMIA – BIOLOGY, PROGNOSIS AND CLINICAL PICTURES (PART 1)
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová
(5/2008, Review articles ) - HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMOPOIETIC CELL TRANSPLANTATION
MUDr. Ján Gyárfáš
(5/2008, Review articles ) - Kritériá minimálnej reziduálnej choroby pri chronickej lymfocytovej leukémii
MUDr. Juliana Holasová, MUDr. Alexander Wild, RNDr. Soňa Ölvecká, Mgr. Mariana Jacková
(2/2018, Review articles ) - Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
doc. MUDr. Peter Beržinec, CSc.
(1/2015, Information & comments ) - Lymfómové fórum – správa z podujatia
MUDr. Andrej Vranovský
(2/2009, Events ) - Diagnostics and treatment of essential thrombocytemia – is there yet anything new?
Prof. MUDr. Mikuláš Hrubiško, CSc.
(4/2015, Review articles ) - Experience with obinutuzumab in patients with chronic lymphocy
MUDr. Juliana Holasová, MUDr. Alexander Wild, RNDr. Soňa Ölvecká, Mgr. Mariana Jacková
(6/2017, Original articles & case reports ) - NODULE GOITRE AS THE FIRST SYMPTOM OF NON-HODGKIN LYMPHOMA/B-CLL: FROM THYROID GLAND DISEASE TO BLOOD DISORDER – CASE REPORT
MUDr. Ľubica Váleková, MUDr. Katarína Macháleková, MUDr. Peter Kentoš, MUDr. Mikuláš Pura, MUDr. Peter Szépe, CSc., Ing. Jana Fedorová, MUDr. Peter Vaňuga
(3/2008, Original articles ) - Acute hematologic emergencies in oncology
MUDr. Ľudmila Krištof
(1/2012, Review articles ) - Metabolic complications in oncology
MUDr. Zuzana Syčová-Milá
(1/2012, Review articles ) - Acalabrutinib, a new Bruton's tyrosine kinase inhibitor in first line CLL treatment
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD.
(2/2023, Review articles ) - CHRONIC LYMPHOCYTIC LEUKEMIA – STAGING AND TREATMENT (PART 2)
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová
(6/2008, Review articles ) - Selected epidemiological aspects of chronic lymphocytic leukaemia in Slovakia: results from the cross-sectional study
MUDr. Eva Mikušková, PhD., MUDr. Elena Marušáková, MBA, doc. MUDr. Ľuboš Drgoňa, CSc., MUDr. Emília Flochová, PhD., MUDr. Tomáš Guman, PhD., Prof. MUDr. Mikuláš Hrubiško, CSc., MUDr. Juraj Chudej, PhD., MUDr. Jana Jurkovičová, Prof. MUDr. Eva Králíková, CSc., MUDr. Miroslav Šimek, PhD., MUDr. Natália Štecová, MVDr. Martina Vulganová
(1/2020, Original articles ) - Monoclonal antibodies in antitumorous therapy and infectious complications
MUDr. Ľuboš Drgoňa, CSc.
(6/2010, Review articles ) - Molecular cythogenetic in the familial cancers
Ing. Martin Čermák
(2/2015, Main topic ) - Molecular pathology of diffuse large B-cell lymphoma – a review
prof. MUDr. Lukáš Plank, CSc., MUDr. Tomáš Balhárek, PhD., MUDr. Jozef Mičák
(2/2015, Spectrum ) - First experience with oropharyngeal mucositis pain treatment with the use of transdermal buprenorphine
Samuel Vokurka, Jana Škardová, Michal Karas, Jana Kostková
(6/2010, Original articles & case reports ) - Establishing diagnosis of hairy cell leukemia (HCL) and identification of the extent of the minimal residual disease (MRD) with flow cytometry of bone marrow aspirate and immunochemistry of trephine biopsy
MUDr. Radoslav Greksák, PhD.
(6/2012, Original articles & case reports ) - Indolentné B-bunkové non-Hodgkinove lymfómy – úvodné slovo
Prof. MUDr. Elena Tóthová, CSc.
(1/2017, Spectrum ) - Differential diagnostics of pulmonary infiltrative process in a patient with chronic lymphocytic leukemia (CLL) – case report
MUDr. Pavol Hollý, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ivana Plameňová, PhD., MUDr. Ivana Babinská, MUDr. Mária Hladká
(6/2012, Original articles & case reports ) - Biology of malignant lymphomas
prof. MUDr. Lukáš Plank, CSc., MUDr. Tomáš Balhárek, PhD.
(2/2014, Main topic ) - Treatment of indolent B-cell lymphomas
MUDr. Veronika Ballová
(2/2014, Main topic ) - Current treatment trends for multiple myeloma – subcutaneous administration of proteasome inhibitor
MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Janka Baňáková, MUDr. Hilda Šajgalíková, MUDr. Miroslav Šimek, PhD.
(2/2014, Review articles ) - Chronic lymphocytic leukaemia (editorial)
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2014, Oncohematology Review ) - Správa z ASH
MUDr. Andrej Vranovský, PhD.
(2/2014, Events ) - Chronic lymphocytic leukemia – genetics
MUDr. Lucia Copáková, RNDr. Michaela Leitnerová, RNDr. Barbora Piačková
(2/2014, Oncohematology Review ) - Pathogenesis of chronic lymphocytic leukemia
MUDr. Ľudmila Demitrovičová, MUDr. Eva Mikušková
(2/2014, Oncohematology Review ) - Laborathory diagnosis of CLL: cytology, flow cytometry
MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD.
(3/2014, Oncohematology Review ) - Initial treatment of chronic lymphocytic leukaemia
MUDr. Emília Flochová, PhD.
(5/2014, Oncohematology Review ) - DID THE INTRODUCTION OF TARGETED THERAPY LIMIT THE IMPORTANCE OF CYTOSTATIC TREATMENT ?
prof. MUDr. Pavel Klener, DrSc.
(6/2007, Review articles ) - Treatment of relapse and refractory chronic lymphocytic leukemia
MUDr. Natália Štecová
(5/2014, Oncohematology Review ) - Classification of cutanoues malignant lymphomas according to recently published new WHO classification (2008)
prof. MUDr. Lukáš Plank, CSc., MUDr. Martina Bobrovská, MUDr. Eva Minariková, PhD., prof. MUDr. Juraj Péč, CSc.
(3/2009, Review articles ) - ASCO 2008, SPRÁVA Z MEDZINÁRODNÉHO STRETNUTIA ONKOLÓGOV
MUDr. Marcela Tkáčová
(4/2008, Events ) - Suplement - Stratégia liečby malígnych lymfómov
(1/2018, online attachment ) - Prognostické faktory pri chronickej lymfocytovej leukémii
MUDr. Ľudmila Demitrovičová, PhD.
(4/2018, Review articles ) - Role of pathologist in the management of chronic lymphocytic leukaemia
MUDr. Tomáš Balhárek, PhD., prof. MUDr. Lukáš Plank, CSc.1
(6/2014, Oncohematology Review )
- Nové liečivá v EÚ registrované v roku 2014 (IV.)
PharmDr. Peter Stanko, Mgr. Zuzana Černáková
(3-4/2015, New drugs ) - New therapy options for multiple sclerosis
Mgr. Ivana Pankuchová, MUDr. Ľubica Procházková, CSc., PharmDr. Adela Čorejová, PhD.
(4/2013, Current pharmacotherapy )